nodes	percent_of_prediction	percent_of_DWPC	metapath
Floxuridine—Zidovudine—acquired immunodeficiency syndrome	0.279	0.5	CrCtD
Floxuridine—Stavudine—acquired immunodeficiency syndrome	0.279	0.5	CrCtD
Floxuridine—Zidovudine—Stavudine—acquired immunodeficiency syndrome	0.0464	0.127	CrCrCtD
Floxuridine—Stavudine—Zidovudine—acquired immunodeficiency syndrome	0.0464	0.127	CrCrCtD
Floxuridine—Emtricitabine—Lamivudine—acquired immunodeficiency syndrome	0.042	0.115	CrCrCtD
Floxuridine—Trifluridine—Stavudine—acquired immunodeficiency syndrome	0.0319	0.0872	CrCrCtD
Floxuridine—Trifluridine—Zidovudine—acquired immunodeficiency syndrome	0.0319	0.0872	CrCrCtD
Floxuridine—Telbivudine—Stavudine—acquired immunodeficiency syndrome	0.0319	0.0872	CrCrCtD
Floxuridine—Idoxuridine—Stavudine—acquired immunodeficiency syndrome	0.0319	0.0872	CrCrCtD
Floxuridine—Idoxuridine—Zidovudine—acquired immunodeficiency syndrome	0.0319	0.0872	CrCrCtD
Floxuridine—Telbivudine—Zidovudine—acquired immunodeficiency syndrome	0.0319	0.0872	CrCrCtD
Floxuridine—Cladribine—Abacavir—acquired immunodeficiency syndrome	0.0264	0.0722	CrCrCtD
Floxuridine—Decitabine—Lamivudine—acquired immunodeficiency syndrome	0.0132	0.0361	CrCrCtD
Floxuridine—TYMP—endothelium—acquired immunodeficiency syndrome	0.00241	0.128	CbGeAlD
Floxuridine—TYMP—blood plasma—acquired immunodeficiency syndrome	0.00214	0.114	CbGeAlD
Floxuridine—Cladribine—POLE3—acquired immunodeficiency syndrome	0.00155	0.934	CrCbGaD
Floxuridine—TYMS—skin of body—acquired immunodeficiency syndrome	0.000882	0.0468	CbGeAlD
Floxuridine—TYMP—lymphoid tissue—acquired immunodeficiency syndrome	0.000832	0.0442	CbGeAlD
Floxuridine—TYMP—digestive system—acquired immunodeficiency syndrome	0.000822	0.0436	CbGeAlD
Floxuridine—TYMP—blood—acquired immunodeficiency syndrome	0.000783	0.0416	CbGeAlD
Floxuridine—TYMP—bone marrow—acquired immunodeficiency syndrome	0.000758	0.0402	CbGeAlD
Floxuridine—TYMP—spinal cord—acquired immunodeficiency syndrome	0.000754	0.0401	CbGeAlD
Floxuridine—TYMP—vagina—acquired immunodeficiency syndrome	0.000726	0.0385	CbGeAlD
Floxuridine—TYMS—lymphoid tissue—acquired immunodeficiency syndrome	0.000714	0.0379	CbGeAlD
Floxuridine—TYMS—digestive system—acquired immunodeficiency syndrome	0.000705	0.0374	CbGeAlD
Floxuridine—TYMP—lung—acquired immunodeficiency syndrome	0.000687	0.0365	CbGeAlD
Floxuridine—TYMS—blood—acquired immunodeficiency syndrome	0.000672	0.0357	CbGeAlD
Floxuridine—TYMS—bone marrow—acquired immunodeficiency syndrome	0.00065	0.0345	CbGeAlD
Floxuridine—TYMP—nervous system—acquired immunodeficiency syndrome	0.000636	0.0338	CbGeAlD
Floxuridine—TYMS—vagina—acquired immunodeficiency syndrome	0.000623	0.0331	CbGeAlD
Floxuridine—TYMP—central nervous system—acquired immunodeficiency syndrome	0.000612	0.0325	CbGeAlD
Floxuridine—TYMS—lung—acquired immunodeficiency syndrome	0.000589	0.0313	CbGeAlD
Floxuridine—TYMS—nervous system—acquired immunodeficiency syndrome	0.000545	0.029	CbGeAlD
Floxuridine—TYMS—central nervous system—acquired immunodeficiency syndrome	0.000525	0.0279	CbGeAlD
Floxuridine—TYMP—brain—acquired immunodeficiency syndrome	0.000486	0.0258	CbGeAlD
Floxuridine—TYMP—lymph node—acquired immunodeficiency syndrome	0.00047	0.0249	CbGeAlD
Floxuridine—TYMS—brain—acquired immunodeficiency syndrome	0.000417	0.0221	CbGeAlD
Floxuridine—TYMS—lymph node—acquired immunodeficiency syndrome	0.000403	0.0214	CbGeAlD
Floxuridine—Thrombocytopenia—Abacavir—acquired immunodeficiency syndrome	0.000141	0.00249	CcSEcCtD
Floxuridine—Epistaxis—Saquinavir—acquired immunodeficiency syndrome	0.00014	0.00248	CcSEcCtD
Floxuridine—Malaise—Zidovudine—acquired immunodeficiency syndrome	0.00014	0.00248	CcSEcCtD
Floxuridine—Anorexia—Nelfinavir—acquired immunodeficiency syndrome	0.000139	0.00247	CcSEcCtD
Floxuridine—Haemoglobin—Ritonavir—acquired immunodeficiency syndrome	0.000139	0.00247	CcSEcCtD
Floxuridine—Leukopenia—Zidovudine—acquired immunodeficiency syndrome	0.000139	0.00246	CcSEcCtD
Floxuridine—Anorexia—Stavudine—acquired immunodeficiency syndrome	0.000139	0.00246	CcSEcCtD
Floxuridine—Muscle spasms—Indinavir—acquired immunodeficiency syndrome	0.000139	0.00246	CcSEcCtD
Floxuridine—Haemorrhage—Ritonavir—acquired immunodeficiency syndrome	0.000139	0.00246	CcSEcCtD
Floxuridine—Alopecia—Efavirenz—acquired immunodeficiency syndrome	0.000139	0.00245	CcSEcCtD
Floxuridine—Stomatitis—Lamivudine—acquired immunodeficiency syndrome	0.000138	0.00245	CcSEcCtD
Floxuridine—Pharyngitis—Ritonavir—acquired immunodeficiency syndrome	0.000138	0.00244	CcSEcCtD
Floxuridine—Gastrointestinal pain—Didanosine—acquired immunodeficiency syndrome	0.000137	0.00243	CcSEcCtD
Floxuridine—Anorexia—Abacavir—acquired immunodeficiency syndrome	0.000137	0.00242	CcSEcCtD
Floxuridine—Erythema—Efavirenz—acquired immunodeficiency syndrome	0.000136	0.00242	CcSEcCtD
Floxuridine—Haemoglobin—Saquinavir—acquired immunodeficiency syndrome	0.000134	0.00237	CcSEcCtD
Floxuridine—Ill-defined disorder—Indinavir—acquired immunodeficiency syndrome	0.000134	0.00237	CcSEcCtD
Floxuridine—Epistaxis—Lamivudine—acquired immunodeficiency syndrome	0.000134	0.00237	CcSEcCtD
Floxuridine—Haemorrhage—Saquinavir—acquired immunodeficiency syndrome	0.000134	0.00236	CcSEcCtD
Floxuridine—Anaemia—Indinavir—acquired immunodeficiency syndrome	0.000134	0.00236	CcSEcCtD
Floxuridine—Abdominal pain—Didanosine—acquired immunodeficiency syndrome	0.000133	0.00235	CcSEcCtD
Floxuridine—Body temperature increased—Didanosine—acquired immunodeficiency syndrome	0.000133	0.00235	CcSEcCtD
Floxuridine—Alopecia—Delavirdine—acquired immunodeficiency syndrome	0.000133	0.00235	CcSEcCtD
Floxuridine—Pharyngitis—Saquinavir—acquired immunodeficiency syndrome	0.000133	0.00235	CcSEcCtD
Floxuridine—Agranulocytosis—Lamivudine—acquired immunodeficiency syndrome	0.000132	0.00234	CcSEcCtD
Floxuridine—Asthenia—Amprenavir—acquired immunodeficiency syndrome	0.000132	0.00234	CcSEcCtD
Floxuridine—Decreased appetite—Nevirapine—acquired immunodeficiency syndrome	0.000131	0.00232	CcSEcCtD
Floxuridine—Discomfort—Zidovudine—acquired immunodeficiency syndrome	0.000131	0.00231	CcSEcCtD
Floxuridine—Erythema—Delavirdine—acquired immunodeficiency syndrome	0.000131	0.00231	CcSEcCtD
Floxuridine—Malaise—Indinavir—acquired immunodeficiency syndrome	0.00013	0.00231	CcSEcCtD
Floxuridine—Confusional state—Zidovudine—acquired immunodeficiency syndrome	0.000128	0.00226	CcSEcCtD
Floxuridine—Decreased appetite—Nelfinavir—acquired immunodeficiency syndrome	0.000127	0.00225	CcSEcCtD
Floxuridine—Decreased appetite—Stavudine—acquired immunodeficiency syndrome	0.000127	0.00224	CcSEcCtD
Floxuridine—Anaphylactic shock—Zidovudine—acquired immunodeficiency syndrome	0.000127	0.00224	CcSEcCtD
Floxuridine—Ill-defined disorder—Efavirenz—acquired immunodeficiency syndrome	0.000127	0.00224	CcSEcCtD
Floxuridine—Pharyngitis—Lamivudine—acquired immunodeficiency syndrome	0.000126	0.00224	CcSEcCtD
Floxuridine—Anaemia—Efavirenz—acquired immunodeficiency syndrome	0.000126	0.00223	CcSEcCtD
Floxuridine—Diarrhoea—Amprenavir—acquired immunodeficiency syndrome	0.000126	0.00223	CcSEcCtD
Floxuridine—Muscle spasms—Delavirdine—acquired immunodeficiency syndrome	0.000126	0.00222	CcSEcCtD
Floxuridine—Decreased appetite—Abacavir—acquired immunodeficiency syndrome	0.000125	0.00221	CcSEcCtD
Floxuridine—Feeling abnormal—Nevirapine—acquired immunodeficiency syndrome	0.000124	0.0022	CcSEcCtD
Floxuridine—Nervous system disorder—Zidovudine—acquired immunodeficiency syndrome	0.000124	0.0022	CcSEcCtD
Floxuridine—Thrombocytopenia—Zidovudine—acquired immunodeficiency syndrome	0.000124	0.0022	CcSEcCtD
Floxuridine—Hypersensitivity—Didanosine—acquired immunodeficiency syndrome	0.000124	0.00219	CcSEcCtD
Floxuridine—Gastrointestinal pain—Nevirapine—acquired immunodeficiency syndrome	0.000124	0.00219	CcSEcCtD
Floxuridine—Malaise—Efavirenz—acquired immunodeficiency syndrome	0.000123	0.00218	CcSEcCtD
Floxuridine—Discomfort—Indinavir—acquired immunodeficiency syndrome	0.000122	0.00215	CcSEcCtD
Floxuridine—Ill-defined disorder—Delavirdine—acquired immunodeficiency syndrome	0.000121	0.00214	CcSEcCtD
Floxuridine—Anorexia—Zidovudine—acquired immunodeficiency syndrome	0.000121	0.00214	CcSEcCtD
Floxuridine—Anaemia—Delavirdine—acquired immunodeficiency syndrome	0.000121	0.00214	CcSEcCtD
Floxuridine—Feeling abnormal—Nelfinavir—acquired immunodeficiency syndrome	0.000121	0.00213	CcSEcCtD
Floxuridine—Asthenia—Didanosine—acquired immunodeficiency syndrome	0.000121	0.00213	CcSEcCtD
Floxuridine—Gastrointestinal pain—Nelfinavir—acquired immunodeficiency syndrome	0.00012	0.00212	CcSEcCtD
Floxuridine—Abdominal pain—Nevirapine—acquired immunodeficiency syndrome	0.000119	0.00211	CcSEcCtD
Floxuridine—Body temperature increased—Nevirapine—acquired immunodeficiency syndrome	0.000119	0.00211	CcSEcCtD
Floxuridine—Gastrointestinal pain—Stavudine—acquired immunodeficiency syndrome	0.000119	0.00211	CcSEcCtD
Floxuridine—Feeling abnormal—Abacavir—acquired immunodeficiency syndrome	0.000118	0.0021	CcSEcCtD
Floxuridine—Alopecia—Saquinavir—acquired immunodeficiency syndrome	0.000118	0.00209	CcSEcCtD
Floxuridine—Anaphylactic shock—Indinavir—acquired immunodeficiency syndrome	0.000118	0.00209	CcSEcCtD
Floxuridine—Malaise—Delavirdine—acquired immunodeficiency syndrome	0.000118	0.00208	CcSEcCtD
Floxuridine—Gastrointestinal pain—Abacavir—acquired immunodeficiency syndrome	0.000117	0.00208	CcSEcCtD
Floxuridine—Vomiting—Amprenavir—acquired immunodeficiency syndrome	0.000117	0.00207	CcSEcCtD
Floxuridine—Leukopenia—Delavirdine—acquired immunodeficiency syndrome	0.000117	0.00207	CcSEcCtD
Floxuridine—Erythema—Saquinavir—acquired immunodeficiency syndrome	0.000116	0.00206	CcSEcCtD
Floxuridine—Rash—Amprenavir—acquired immunodeficiency syndrome	0.000116	0.00206	CcSEcCtD
Floxuridine—Muscle spasms—Ritonavir—acquired immunodeficiency syndrome	0.000116	0.00205	CcSEcCtD
Floxuridine—Dermatitis—Amprenavir—acquired immunodeficiency syndrome	0.000116	0.00205	CcSEcCtD
Floxuridine—Body temperature increased—Nelfinavir—acquired immunodeficiency syndrome	0.000116	0.00205	CcSEcCtD
Floxuridine—Abdominal pain—Nelfinavir—acquired immunodeficiency syndrome	0.000116	0.00205	CcSEcCtD
Floxuridine—Nervous system disorder—Indinavir—acquired immunodeficiency syndrome	0.000116	0.00205	CcSEcCtD
Floxuridine—Headache—Amprenavir—acquired immunodeficiency syndrome	0.000115	0.00204	CcSEcCtD
Floxuridine—Thrombocytopenia—Indinavir—acquired immunodeficiency syndrome	0.000115	0.00204	CcSEcCtD
Floxuridine—Abdominal pain—Stavudine—acquired immunodeficiency syndrome	0.000115	0.00204	CcSEcCtD
Floxuridine—Body temperature increased—Stavudine—acquired immunodeficiency syndrome	0.000115	0.00204	CcSEcCtD
Floxuridine—Diarrhoea—Didanosine—acquired immunodeficiency syndrome	0.000115	0.00203	CcSEcCtD
Floxuridine—Discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000115	0.00203	CcSEcCtD
Floxuridine—Abdominal pain—Abacavir—acquired immunodeficiency syndrome	0.000114	0.00201	CcSEcCtD
Floxuridine—Body temperature increased—Abacavir—acquired immunodeficiency syndrome	0.000114	0.00201	CcSEcCtD
Floxuridine—Alopecia—Lamivudine—acquired immunodeficiency syndrome	0.000113	0.00199	CcSEcCtD
Floxuridine—Anorexia—Indinavir—acquired immunodeficiency syndrome	0.000112	0.00199	CcSEcCtD
Floxuridine—Confusional state—Efavirenz—acquired immunodeficiency syndrome	0.000112	0.00199	CcSEcCtD
Floxuridine—Ill-defined disorder—Ritonavir—acquired immunodeficiency syndrome	0.000112	0.00198	CcSEcCtD
Floxuridine—Muscle spasms—Saquinavir—acquired immunodeficiency syndrome	0.000112	0.00198	CcSEcCtD
Floxuridine—Anaemia—Ritonavir—acquired immunodeficiency syndrome	0.000112	0.00198	CcSEcCtD
Floxuridine—Hypersensitivity—Nevirapine—acquired immunodeficiency syndrome	0.000111	0.00197	CcSEcCtD
Floxuridine—Erythema—Lamivudine—acquired immunodeficiency syndrome	0.000111	0.00196	CcSEcCtD
Floxuridine—Decreased appetite—Zidovudine—acquired immunodeficiency syndrome	0.00011	0.00195	CcSEcCtD
Floxuridine—Discomfort—Delavirdine—acquired immunodeficiency syndrome	0.00011	0.00194	CcSEcCtD
Floxuridine—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.000109	0.00194	CcSEcCtD
Floxuridine—Nervous system disorder—Efavirenz—acquired immunodeficiency syndrome	0.000109	0.00193	CcSEcCtD
Floxuridine—Zidovudine—ALB—acquired immunodeficiency syndrome	0.000109	0.0659	CrCbGaD
Floxuridine—Thrombocytopenia—Efavirenz—acquired immunodeficiency syndrome	0.000109	0.00193	CcSEcCtD
Floxuridine—Malaise—Ritonavir—acquired immunodeficiency syndrome	0.000109	0.00193	CcSEcCtD
Floxuridine—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.000108	0.00192	CcSEcCtD
Floxuridine—Leukopenia—Ritonavir—acquired immunodeficiency syndrome	0.000108	0.00191	CcSEcCtD
Floxuridine—Ill-defined disorder—Saquinavir—acquired immunodeficiency syndrome	0.000108	0.00191	CcSEcCtD
Floxuridine—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.000108	0.00191	CcSEcCtD
Floxuridine—Confusional state—Delavirdine—acquired immunodeficiency syndrome	0.000107	0.0019	CcSEcCtD
Floxuridine—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.000107	0.0019	CcSEcCtD
Floxuridine—Anaemia—Saquinavir—acquired immunodeficiency syndrome	0.000107	0.0019	CcSEcCtD
Floxuridine—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.000107	0.00189	CcSEcCtD
Floxuridine—Muscle spasms—Lamivudine—acquired immunodeficiency syndrome	0.000107	0.00189	CcSEcCtD
Floxuridine—Anorexia—Efavirenz—acquired immunodeficiency syndrome	0.000106	0.00188	CcSEcCtD
Floxuridine—Rash—Didanosine—acquired immunodeficiency syndrome	0.000106	0.00187	CcSEcCtD
Floxuridine—Infection—Delavirdine—acquired immunodeficiency syndrome	0.000106	0.00187	CcSEcCtD
Floxuridine—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.000106	0.00187	CcSEcCtD
Floxuridine—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000106	0.00187	CcSEcCtD
Floxuridine—Headache—Didanosine—acquired immunodeficiency syndrome	0.000105	0.00186	CcSEcCtD
Floxuridine—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.000105	0.00186	CcSEcCtD
Floxuridine—Malaise—Saquinavir—acquired immunodeficiency syndrome	0.000105	0.00185	CcSEcCtD
Floxuridine—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000105	0.00185	CcSEcCtD
Floxuridine—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.000104	0.00185	CcSEcCtD
Floxuridine—Thrombocytopenia—Delavirdine—acquired immunodeficiency syndrome	0.000104	0.00185	CcSEcCtD
Floxuridine—Leukopenia—Saquinavir—acquired immunodeficiency syndrome	0.000104	0.00184	CcSEcCtD
Floxuridine—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.000104	0.00183	CcSEcCtD
Floxuridine—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000103	0.00183	CcSEcCtD
Floxuridine—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000103	0.00182	CcSEcCtD
Floxuridine—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	0.000103	0.00182	CcSEcCtD
Floxuridine—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.000102	0.00181	CcSEcCtD
Floxuridine—Anaemia—Lamivudine—acquired immunodeficiency syndrome	0.000102	0.00181	CcSEcCtD
Floxuridine—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.000102	0.0018	CcSEcCtD
Floxuridine—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000102	0.0018	CcSEcCtD
Floxuridine—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.0001	0.00177	CcSEcCtD
Floxuridine—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.0001	0.00177	CcSEcCtD
Floxuridine—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.0001	0.00177	CcSEcCtD
Floxuridine—Malaise—Lamivudine—acquired immunodeficiency syndrome	0.0001	0.00177	CcSEcCtD
Floxuridine—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	9.98e-05	0.00177	CcSEcCtD
Floxuridine—Nausea—Didanosine—acquired immunodeficiency syndrome	9.98e-05	0.00177	CcSEcCtD
Floxuridine—Confusional state—Ritonavir—acquired immunodeficiency syndrome	9.94e-05	0.00176	CcSEcCtD
Floxuridine—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	9.93e-05	0.00176	CcSEcCtD
Floxuridine—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	9.83e-05	0.00174	CcSEcCtD
Floxuridine—Discomfort—Saquinavir—acquired immunodeficiency syndrome	9.78e-05	0.00173	CcSEcCtD
Floxuridine—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	9.71e-05	0.00172	CcSEcCtD
Floxuridine—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	9.68e-05	0.00171	CcSEcCtD
Floxuridine—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	9.66e-05	0.00171	CcSEcCtD
Floxuridine—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	9.65e-05	0.00171	CcSEcCtD
Floxuridine—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	9.64e-05	0.00171	CcSEcCtD
Floxuridine—Vomiting—Nevirapine—acquired immunodeficiency syndrome	9.6e-05	0.0017	CcSEcCtD
Floxuridine—Confusional state—Saquinavir—acquired immunodeficiency syndrome	9.56e-05	0.00169	CcSEcCtD
Floxuridine—Rash—Nevirapine—acquired immunodeficiency syndrome	9.52e-05	0.00169	CcSEcCtD
Floxuridine—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	9.52e-05	0.00168	CcSEcCtD
Floxuridine—Headache—Nevirapine—acquired immunodeficiency syndrome	9.46e-05	0.00167	CcSEcCtD
Floxuridine—Infection—Saquinavir—acquired immunodeficiency syndrome	9.42e-05	0.00167	CcSEcCtD
Floxuridine—Anorexia—Ritonavir—acquired immunodeficiency syndrome	9.39e-05	0.00166	CcSEcCtD
Floxuridine—Discomfort—Lamivudine—acquired immunodeficiency syndrome	9.33e-05	0.00165	CcSEcCtD
Floxuridine—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	9.32e-05	0.00165	CcSEcCtD
Floxuridine—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	9.32e-05	0.00165	CcSEcCtD
Floxuridine—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	9.3e-05	0.00165	CcSEcCtD
Floxuridine—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	9.3e-05	0.00165	CcSEcCtD
Floxuridine—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	9.29e-05	0.00164	CcSEcCtD
Floxuridine—Vomiting—Stavudine—acquired immunodeficiency syndrome	9.27e-05	0.00164	CcSEcCtD
Floxuridine—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	9.26e-05	0.00164	CcSEcCtD
Floxuridine—Rash—Nelfinavir—acquired immunodeficiency syndrome	9.22e-05	0.00163	CcSEcCtD
Floxuridine—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	9.22e-05	0.00163	CcSEcCtD
Floxuridine—Rash—Stavudine—acquired immunodeficiency syndrome	9.2e-05	0.00163	CcSEcCtD
Floxuridine—Dermatitis—Stavudine—acquired immunodeficiency syndrome	9.19e-05	0.00163	CcSEcCtD
Floxuridine—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	9.18e-05	0.00162	CcSEcCtD
Floxuridine—Headache—Nelfinavir—acquired immunodeficiency syndrome	9.16e-05	0.00162	CcSEcCtD
Floxuridine—Headache—Stavudine—acquired immunodeficiency syndrome	9.14e-05	0.00162	CcSEcCtD
Floxuridine—Vomiting—Abacavir—acquired immunodeficiency syndrome	9.14e-05	0.00162	CcSEcCtD
Floxuridine—Confusional state—Lamivudine—acquired immunodeficiency syndrome	9.12e-05	0.00161	CcSEcCtD
Floxuridine—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	9.11e-05	0.00161	CcSEcCtD
Floxuridine—Asthenia—Zidovudine—acquired immunodeficiency syndrome	9.1e-05	0.00161	CcSEcCtD
Floxuridine—Rash—Abacavir—acquired immunodeficiency syndrome	9.06e-05	0.0016	CcSEcCtD
Floxuridine—Dermatitis—Abacavir—acquired immunodeficiency syndrome	9.05e-05	0.0016	CcSEcCtD
Floxuridine—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	9.05e-05	0.0016	CcSEcCtD
Floxuridine—Anorexia—Saquinavir—acquired immunodeficiency syndrome	9.04e-05	0.0016	CcSEcCtD
Floxuridine—Headache—Abacavir—acquired immunodeficiency syndrome	9e-05	0.00159	CcSEcCtD
Floxuridine—Infection—Lamivudine—acquired immunodeficiency syndrome	8.99e-05	0.00159	CcSEcCtD
Floxuridine—Nausea—Nevirapine—acquired immunodeficiency syndrome	8.97e-05	0.00159	CcSEcCtD
Floxuridine—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	8.87e-05	0.00157	CcSEcCtD
Floxuridine—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	8.86e-05	0.00157	CcSEcCtD
Floxuridine—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	8.81e-05	0.00156	CcSEcCtD
Floxuridine—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	8.81e-05	0.00156	CcSEcCtD
Floxuridine—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	8.78e-05	0.00155	CcSEcCtD
Floxuridine—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	8.71e-05	0.00154	CcSEcCtD
Floxuridine—Nausea—Nelfinavir—acquired immunodeficiency syndrome	8.69e-05	0.00154	CcSEcCtD
Floxuridine—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	8.69e-05	0.00154	CcSEcCtD
Floxuridine—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	8.67e-05	0.00153	CcSEcCtD
Floxuridine—Nausea—Stavudine—acquired immunodeficiency syndrome	8.66e-05	0.00153	CcSEcCtD
Floxuridine—Anorexia—Lamivudine—acquired immunodeficiency syndrome	8.63e-05	0.00153	CcSEcCtD
Floxuridine—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	8.57e-05	0.00152	CcSEcCtD
Floxuridine—Nausea—Abacavir—acquired immunodeficiency syndrome	8.53e-05	0.00151	CcSEcCtD
Floxuridine—Asthenia—Indinavir—acquired immunodeficiency syndrome	8.46e-05	0.0015	CcSEcCtD
Floxuridine—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	8.42e-05	0.00149	CcSEcCtD
Floxuridine—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	8.42e-05	0.00149	CcSEcCtD
Floxuridine—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	8.25e-05	0.00146	CcSEcCtD
Floxuridine—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	8.21e-05	0.00145	CcSEcCtD
Floxuridine—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	8.12e-05	0.00144	CcSEcCtD
Floxuridine—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	8.07e-05	0.00143	CcSEcCtD
Floxuridine—Vomiting—Zidovudine—acquired immunodeficiency syndrome	8.06e-05	0.00143	CcSEcCtD
Floxuridine—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	8.06e-05	0.00143	CcSEcCtD
Floxuridine—Rash—Zidovudine—acquired immunodeficiency syndrome	7.99e-05	0.00141	CcSEcCtD
Floxuridine—Asthenia—Efavirenz—acquired immunodeficiency syndrome	7.99e-05	0.00141	CcSEcCtD
Floxuridine—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	7.99e-05	0.00141	CcSEcCtD
Floxuridine—Headache—Zidovudine—acquired immunodeficiency syndrome	7.94e-05	0.00141	CcSEcCtD
Floxuridine—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	7.87e-05	0.00139	CcSEcCtD
Floxuridine—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	7.85e-05	0.00139	CcSEcCtD
Floxuridine—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	7.82e-05	0.00138	CcSEcCtD
Floxuridine—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	7.79e-05	0.00138	CcSEcCtD
Floxuridine—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	7.79e-05	0.00138	CcSEcCtD
Floxuridine—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	7.76e-05	0.00137	CcSEcCtD
Floxuridine—Asthenia—Delavirdine—acquired immunodeficiency syndrome	7.65e-05	0.00135	CcSEcCtD
Floxuridine—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	7.62e-05	0.00135	CcSEcCtD
Floxuridine—Nausea—Zidovudine—acquired immunodeficiency syndrome	7.53e-05	0.00133	CcSEcCtD
Floxuridine—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	7.5e-05	0.00133	CcSEcCtD
Floxuridine—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	7.5e-05	0.00133	CcSEcCtD
Floxuridine—Vomiting—Indinavir—acquired immunodeficiency syndrome	7.5e-05	0.00133	CcSEcCtD
Floxuridine—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	7.46e-05	0.00132	CcSEcCtD
Floxuridine—Rash—Indinavir—acquired immunodeficiency syndrome	7.43e-05	0.00132	CcSEcCtD
Floxuridine—Dermatitis—Indinavir—acquired immunodeficiency syndrome	7.43e-05	0.00131	CcSEcCtD
Floxuridine—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	7.4e-05	0.00131	CcSEcCtD
Floxuridine—Headache—Indinavir—acquired immunodeficiency syndrome	7.39e-05	0.00131	CcSEcCtD
Floxuridine—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	7.29e-05	0.00129	CcSEcCtD
Floxuridine—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	7.26e-05	0.00129	CcSEcCtD
Floxuridine—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	7.15e-05	0.00127	CcSEcCtD
Floxuridine—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	7.15e-05	0.00127	CcSEcCtD
Floxuridine—Vomiting—Efavirenz—acquired immunodeficiency syndrome	7.08e-05	0.00125	CcSEcCtD
Floxuridine—Asthenia—Ritonavir—acquired immunodeficiency syndrome	7.07e-05	0.00125	CcSEcCtD
Floxuridine—Rash—Efavirenz—acquired immunodeficiency syndrome	7.02e-05	0.00124	CcSEcCtD
Floxuridine—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	7.02e-05	0.00124	CcSEcCtD
Floxuridine—Nausea—Indinavir—acquired immunodeficiency syndrome	7e-05	0.00124	CcSEcCtD
Floxuridine—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	6.99e-05	0.00124	CcSEcCtD
Floxuridine—Headache—Efavirenz—acquired immunodeficiency syndrome	6.98e-05	0.00123	CcSEcCtD
Floxuridine—Asthenia—Saquinavir—acquired immunodeficiency syndrome	6.81e-05	0.0012	CcSEcCtD
Floxuridine—Vomiting—Delavirdine—acquired immunodeficiency syndrome	6.78e-05	0.0012	CcSEcCtD
Floxuridine—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	6.74e-05	0.00119	CcSEcCtD
Floxuridine—Rash—Delavirdine—acquired immunodeficiency syndrome	6.72e-05	0.00119	CcSEcCtD
Floxuridine—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	6.71e-05	0.00119	CcSEcCtD
Floxuridine—Headache—Delavirdine—acquired immunodeficiency syndrome	6.68e-05	0.00118	CcSEcCtD
Floxuridine—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	6.67e-05	0.00118	CcSEcCtD
Floxuridine—Nausea—Efavirenz—acquired immunodeficiency syndrome	6.62e-05	0.00117	CcSEcCtD
Floxuridine—Asthenia—Lamivudine—acquired immunodeficiency syndrome	6.49e-05	0.00115	CcSEcCtD
Floxuridine—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	6.49e-05	0.00115	CcSEcCtD
Floxuridine—Nausea—Delavirdine—acquired immunodeficiency syndrome	6.33e-05	0.00112	CcSEcCtD
Floxuridine—Vomiting—Ritonavir—acquired immunodeficiency syndrome	6.27e-05	0.00111	CcSEcCtD
Floxuridine—Rash—Ritonavir—acquired immunodeficiency syndrome	6.21e-05	0.0011	CcSEcCtD
Floxuridine—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	6.21e-05	0.0011	CcSEcCtD
Floxuridine—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	6.19e-05	0.0011	CcSEcCtD
Floxuridine—Headache—Ritonavir—acquired immunodeficiency syndrome	6.17e-05	0.00109	CcSEcCtD
Floxuridine—Vomiting—Saquinavir—acquired immunodeficiency syndrome	6.03e-05	0.00107	CcSEcCtD
Floxuridine—Rash—Saquinavir—acquired immunodeficiency syndrome	5.98e-05	0.00106	CcSEcCtD
Floxuridine—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	5.98e-05	0.00106	CcSEcCtD
Floxuridine—Headache—Saquinavir—acquired immunodeficiency syndrome	5.94e-05	0.00105	CcSEcCtD
Floxuridine—Nausea—Ritonavir—acquired immunodeficiency syndrome	5.85e-05	0.00104	CcSEcCtD
Floxuridine—Vomiting—Lamivudine—acquired immunodeficiency syndrome	5.75e-05	0.00102	CcSEcCtD
Floxuridine—Rash—Lamivudine—acquired immunodeficiency syndrome	5.71e-05	0.00101	CcSEcCtD
Floxuridine—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	5.7e-05	0.00101	CcSEcCtD
Floxuridine—Headache—Lamivudine—acquired immunodeficiency syndrome	5.67e-05	0.001	CcSEcCtD
Floxuridine—Nausea—Saquinavir—acquired immunodeficiency syndrome	5.63e-05	0.000997	CcSEcCtD
Floxuridine—Nausea—Lamivudine—acquired immunodeficiency syndrome	5.38e-05	0.000951	CcSEcCtD
